Ignite Creation Date:
2025-12-25 @ 3:52 AM
Ignite Modification Date:
2026-03-06 @ 12:04 PM
Study NCT ID:
NCT01281202
Status:
COMPLETED
Last Update Posted:
2016-05-18
First Post:
2011-01-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Vigabatrin for the Treatment of Cocaine Dependency
Sponsor:
Catalyst Pharmaceuticals, Inc.
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
CPP-01005/CS# 1030 TRANSFERRED
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None